1. Home
  2. CRDL vs FTLF Comparison

CRDL vs FTLF Comparison

Compare CRDL & FTLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardiol Therapeutics Inc.

CRDL

Cardiol Therapeutics Inc.

HOLD

Current Price

$1.18

Market Cap

132.6M

Sector

Health Care

ML Signal

HOLD

Logo FitLife Brands Inc.

FTLF

FitLife Brands Inc.

HOLD

Current Price

$10.15

Market Cap

112.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRDL
FTLF
Founded
2017
2005
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.6M
112.0M
IPO Year
2017
2006

Fundamental Metrics

Financial Performance
Metric
CRDL
FTLF
Price
$1.18
$10.15
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$8.50
$21.50
AVG Volume (30 Days)
806.5K
18.1K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.17
Revenue
N/A
$21,744,000.00
Revenue This Year
N/A
$45.76
Revenue Next Year
N/A
$5.10
P/E Ratio
N/A
$56.88
Revenue Growth
N/A
11.52
52 Week Low
$0.88
$8.67
52 Week High
$1.71
$20.98

Technical Indicators

Market Signals
Indicator
CRDL
FTLF
Relative Strength Index (RSI) 53.46 37.74
Support Level $0.95 $9.44
Resistance Level $1.38 $12.55
Average True Range (ATR) 0.10 0.46
MACD 0.01 -0.17
Stochastic Oscillator 60.13 16.16

Price Performance

Historical Comparison
CRDL
FTLF

About CRDL Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway activation, which is involved in the development of inflammation and fibrosis in conditions such as pericarditis, myocarditis, and heart failure. The CardiolRx program includes the completed Phase II MAVERIC-Pilot study and the ongoing Phase III MAVERIC trial for the treatment of pericarditis. The ARCHER program evaluated CardiolRx in acute myocarditis through a completed Phase II study. The company is also developing CRD-38, a novel subcutaneous drug formulation for treating inflammatory heart conditions, including heart failure.

About FTLF FitLife Brands Inc.

FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Dr. Tobias, MusclePharm, Irwin Naturals, Applied Nutrition, Isatori, and Nature's Secret brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.

Share on Social Networks: